|
|
||||||||




* Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of
Laboratory Medicine and Pathobiology and
Pediatrics and Physiology, University of Toronto, Toronto, Ontario, Canada; and
Intestinal Disease Research Program, McMaster University, Hamilton, Ontario, Canada
Helicobacter pylori is a bacterial pathogen evolved to chronically colonize the gastric epithelium, evade immune clearance by the host, and cause gastritis, peptic ulcers, and even gastric malignancies in some infected humans. In view of the known ability of this bacterium to manipulate gastric epithelial cell signal transduction cascades, we determined the effects of H. pylori infection on epithelial IL-4-Stat6 signal transduction. HEp-2 and MKN45 epithelial cells were infected with H. pylori strains LC11 or 8823 (type 1; cagA+/cagE+/VacA+), LC20 (type 2; cagA-, cagE-, VacA-), and cagA, cagE, and vacA isogenic mutants of strain 8823, with some cells receiving subsequent treatment with the Th2 cytokine IL-4, a known Stat6 activator. Immunofluorescence showed a disruption of Stat6-induced nuclear translocation by IL-4 in LC11-infected HEp-2 cells. IL-4-inducible Stat6 DNA binding in HEp-2 and MKN45 cells was abrogated by infection, but MKN45 cell viability was unaffected. A decrease in IL-4-mediated Stat6 tyrosine phosphorylation in nuclear and whole cell lysates was also observed following infection with strains LC11 and LC20, while neither strain altered IL-4 receptor chain
or Janus kinase 1 protein expression. Furthermore, parental strain 8823 and its isogenic cagA, cagE, and vacA mutants also suppressed IL-4-induced Stat6 tyrosine phosphorylation to comparable degrees. Thus, H. pylori did not directly activate Stat6, but blocked the IL-4-induced activation of epithelial Stat6. This may represent an evolutionarily conserved strategy to disrupt a Th2 response and evade the host immune system, allowing for successful chronic infection.
This article has been cited by other articles:
![]() |
S. Asonuma, A. Imatani, N. Asano, T. Oikawa, H. Konishi, K. Iijima, T. Koike, S. Ohara, and T. Shimosegawa Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G312 - G322. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bronte-Tinkew, M. Terebiznik, A. Franco, M. Ang, D. Ahn, H. Mimuro, C. Sasakawa, M. J. Ropeleski, R. M. Peek Jr., and N. L. Jones Helicobacter pylori Cytotoxin-Associated Gene A Activates the Signal Transducer and Activator of Transcription 3 Pathway In vitro and In vivo Cancer Res., January 15, 2009; 69(2): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Menaker, P. J. M. Ceponis, and N. L. Jones Helicobacter pylori Induces Apoptosis of Macrophages in Association with Alterations in the Mitochondrial Pathway Infect. Immun., May 1, 2004; 72(5): 2889 - 2898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |